Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, and Valo ...

and Valo Therapeutics Oy (“ValoTx”), a private company developing novel, adaptable immunotherapies for the treatment of cancer, are pleased to announce a preclinical research collaboration to ...

BASKING RIDGE, N.J. - Lisata Therapeutics, Inc. (NASDAQ:LSTA) and Valo Therapeutics Oy (ValoTx ... penetration and accumulation of anti-cancer agents within tumors. This mechanism also modifies ...

Development Portfolio Highlights Certepetide as a treatment for solid tumors in combination with other anti-cancer agents Certepetide is an investigational ... Lisata is also partnering with Valo ...

He’s the millionaire South Australian entrepreneur who this year quit SA for Queensland to capitalise on the Brisbane 2032 ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

This project has not set up a SECURITY.md file yet.

How much do the prices of a 1 bedroom apartment for sale vary in Address Residences? As per the listings on Bayut, you can buy 1 bedroom flats in Address Residences within a budget of AED 2,000,888 to ...

This era is marked by significant developments in AI agents, which are becoming increasingly autonomous, adaptive and context-aware. For my cybersecurity area of focus, I want to point out that ...

Microsoft is rolling out autonomous AI agents for its Copilot software. Users will be able to create their own agents to handle customer management tasks or rely on agents designed by Microsoft.

From next month, businesses will be able to use Microsoft’s Copilot Studio to create autonomous AI agents: interactive systems designed to perform specific tasks and automate user processes.